Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Sep 3, 2026
Reporting period
Not applicable
Filed with the SEC
Sep 5, 2026
CEOIndirect holdingOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001106578-26-000135
Filed / recorded
Sep 5, 2026, 12:31 AM UTC
Added to OQRO
Oct 6, 2026, 9:34 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
UNITED THERAPEUTICS Corp
Issuer CIK
1082554
Ticker
UTHR
Reporting person
Martine A Rothblatt
Relationship
Director, Officer
Officer title
Chairperson & CEO
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Sep 3, 2026
Transaction code
M
Shares / units
590
Price per share
$117.76
Acquired / disposed
Acquired (A)
Shares owned after
333,943
Ownership form
Indirect — by Trust
Amendment
No
Footnotes from the filing
This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.